3C-BOH
pharmaceutical compound
3C-BOH, also known as β-methoxy-3,4-methylenedioxyamphetamine (β-methoxy-MDA) or as BOMDA, is a psychoactive drug of the phenethylamine, amphetamine, MDxx, and BOx families related to 3,4-methylenedioxyamphetamine (MDA). It is the β-methoxy derivative of MDA and the amphetamine (α-methyl) analogue of BOH (β-methoxy-MDPEA). The drug is active at a dose of 40 to 70 mg orally with a duration of 3 to 6 hours. It is said to produce "amphetamine-like effects", as well as physical side effects and temporary body stiffness. 3C-BOH acts as a monoamine releasing agent and reuptake inhibitor, including of serotonin and norepinephrine, and additionally acts as an agonist of the serotonin 5-HT2 receptors, among other actions. The compound can exist as four stereoisomers, with individual assessment of each individual isomer still needed. 3C-BOH was first described in the scientific literature by Daniel Trachsel and colleagues in 2013 via personal communication with another person.
The public source identifies “3C-BOH” as pharmaceutical compound. This brief keeps that definition visible, then builds a research path around 3C-BOH, pharmaceutical and compound.
Why this record matters
A short description can identify a subject without explaining its stakes. For “3C-BOH”, the useful work is to connect “pharmaceutical compound” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jun 8, 2026. The linked authority identifier is Q136773920. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2013.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “3C-BOH”, its source revision and the description used here.
- Expand the search: follow 3C-BOH primary sources, 3C-BOH archive and 3C-BOH research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “3C-BOH”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “3C-BOH” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.